Journal Home
Search for

Volume 4, Issue 2, Pages 126-134 (April 2010)


View previous. 5 of 9 View next.

Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EμMyc lymphomagenesis: A tumor suppressor role for Prep1

E. Longobardiab1, G. Iottib1, P. Di Rosaa, S. Mejettab, F. Bianchib, L.C. Fernandez-Diazb, N. Micalib, P. Nuciforob, E. Lentia, M. Ponzonic, C. Doglionic, M. Caniattid, P.P. Di Fiorebef, F. BlasiabCorresponding Author Informationemail address

Received 25 November 2009; received in revised form 28 December 2009; accepted 4 January 2010. published online 13 January 2010.

Abstract 

The Prep1 homeodomain transcription factor is essential for embryonic development. 25% of hypomorphic Prep1i/i embryos, expressing the gene at 2% of the normal levels, survive pregnancy and live a normal-length life. Later in life, however, these mice develop spontaneous pre-tumoral lesions or solid tumors (lymphomas and carcinomas). In addition, transplantation of E14.5 fetal liver (FL) Prep1i/i cells into lethally irradiated mice induces lymphomas. In agreement with the above data, haploinsufficiency of a different Prep1-deficient (null) allele accelerates EμMyc lymphoma growth. Therefore Prep1 has a tumor suppressor function in mice.

Immunohistochemistry on tissue micrroarrays (TMA) generated from three distinct human cohorts comprising a total of some 1000 human tumors revealed that 70% of the tumors express no or extremely low levels of Prep1, unlike normal tissues. Our data in mice are thus potentially relevant to human cancer.

a Università Vita Salute San Raffaele, via Olgettina 60, Milano 20132, Italy

b IFOM (Fondazione Istituto FIRC di Oncologia Molecolare), IFOM-IEO-Campus, via Adamello 16, 20139 Milano, Italy

c Servizio di Anatomia Patologica, Istituto Scientifico S. Raffaele, via Olgettina 60, 20132 Milano, Italy

d Dipartimento di Patologia, Igiene e Sanità Pubblica Veterinaria, Sezione di Anatomia Patologica Veterinaria e Patologia Aviaria, Università degli Studi di Milano, Via Celoria 10, 20133 Milano, Italy

e Department of Experimental Oncology, Istituto Europeo di Oncologia, IFOM-IEO-Campus, via Adamello 16, 20139 Milan, Italy

f Dipartimento di Medicina, Chirurgia ed Odontoiatria, Università degli Studi di Milano, Via di Rudinì 8, 20122 Milan, Italy

Corresponding Author InformationCorresponding author to: IFOM, via Adamello 16, 20139 Milan, Italy. Tel.: +3902574303288; fax: +3902574303231.

1 Both authors contributed equally to this work.

PII: S1574-7891(10)00002-5

doi:10.1016/j.molonc.2010.01.001


View previous. 5 of 9 View next.